mHealth Intelligence April 22, 2021
Eric Wicklund

The federal agencies are reversing course after a Trump administration proposal to end oversight of dozens of mHealth apps, devices and platforms drew strong opposition from within and outside government.

Federal officials are quietly withdrawing a Trump administration plan to end regulatory review of 83 types of mHealth devices, saying the original plan was flawed and could have put the lives of Americans using that technology in danger.

In a notice posted last week in the Federal Register, the Health and Human Services Department and the Food and Drug Administration announced that they won’t enforce an HHS notice posted on January 15 that, among other things, would have exempted 83 class II devices and one unclassified device from premarket notification....

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Digital Health, FDA, Govt Agencies, HHS, Medical Devices, Regulations, Technology
Responsible Data Use In An Age Of AI
‘Disturbing’ Outlook: Hospices’ Top Regulatory Concerns in 2025
Senate Bill 316: An Overview for North Carolina Hospitals
AI Regulations: Tech Giants and Hollywood Converge on White House AI Strategy
California State Assembly Introduces Bill Expanding Cost Target and Antitrust Rules to Cover Healthcare Industry Investment Groups

Share This Article